156 related articles for article (PubMed ID: 36006505)
21. Totally minimally invasive esophagectomy after neoadjuvant chemoradiotherapy: Long-term oncologic outcomes.
Lubbers M; van Det MJ; Kreuger MJ; Hoekstra R; Hendriksen EM; Vermeer M; Kouwenhoven EA
J Surg Oncol; 2018 Mar; 117(4):651-658. PubMed ID: 29603271
[TBL] [Abstract][Full Text] [Related]
22. Outcomes and survival following neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the esophagus: Inverse propensity score weighted analysis.
Pucher PH; Rahman SA; Walker RC; Grace BL; Bateman A; Iveson T; Jackson A; Rees C; Byrne JP; Kelly JJ; Noble F; Underwood TJ
Eur J Surg Oncol; 2020 Dec; 46(12):2248-2256. PubMed ID: 32694054
[TBL] [Abstract][Full Text] [Related]
23. Changes in pulmonary function tests after neoadjuvant therapy predict postoperative complications.
Cerfolio RJ; Talati A; Bryant AS
Ann Thorac Surg; 2009 Sep; 88(3):930-5; discussion 935-6. PubMed ID: 19699923
[TBL] [Abstract][Full Text] [Related]
24. Minimally invasive esophagectomy is safe and effective following neoadjuvant chemoradiation therapy.
Ben-David K; Rossidis G; Zlotecki RA; Grobmyer SR; Cendan JC; Sarosi GA; Hochwald SN
Ann Surg Oncol; 2011 Nov; 18(12):3324-9. PubMed ID: 21479689
[TBL] [Abstract][Full Text] [Related]
25. Minimally invasive esophagectomy provides significant survival advantage compared with open or hybrid esophagectomy for patients with cancers of the esophagus and gastroesophageal junction.
Palazzo F; Rosato EL; Chaudhary A; Evans NR; Sendecki JA; Keith S; Chojnacki KA; Yeo CJ; Berger AC
J Am Coll Surg; 2015 Apr; 220(4):672-9. PubMed ID: 25667145
[TBL] [Abstract][Full Text] [Related]
26. Impact of neoadjuvant chemoradiotherapy on postoperative course after curative-intent transthoracic esophagectomy in esophageal cancer patients.
Bosch DJ; Muijs CT; Mul VE; Beukema JC; Hospers GA; Burgerhof JG; Plukker JT
Ann Surg Oncol; 2014 Feb; 21(2):605-11. PubMed ID: 24100962
[TBL] [Abstract][Full Text] [Related]
27. Effects of pre-operative enteral immunonutrition for esophageal cancer patients treated with neoadjuvant chemoradiotherapy: protocol for a multicenter randomized controlled trial (point trial, pre-operative immunonutrition therapy).
Cao Y; Han D; Yang S; Shi Y; Zhao S; Jin Q; Li J; Li C; Zhang Y; Shen W; He J; Wang M; Ji G; Li Z; He Y; Chen Q; Wei W; Chen C; Gong X; Wang J; Tan L; Wang H; Li H
BMC Cancer; 2022 Jun; 22(1):650. PubMed ID: 35698100
[TBL] [Abstract][Full Text] [Related]
28. Comparative Perioperative Outcomes by Esophagectomy Surgical Technique.
Meredith KL; Maramara T; Blinn P; Lee D; Huston J; Shridhar R
J Gastrointest Surg; 2020 Jun; 24(6):1261-1268. PubMed ID: 31197697
[TBL] [Abstract][Full Text] [Related]
29. The influence of minimally invasive esophagectomy versus open esophagectomy on postoperative pulmonary function in esophageal cancer patients: a meta-analysis.
Su J; Li S; Sui Q; Wang G
J Cardiothorac Surg; 2022 Jun; 17(1):139. PubMed ID: 35655256
[TBL] [Abstract][Full Text] [Related]
30. Increased risk of thromboembolism in esophageal cancer patients treated with neoadjuvant chemoradiotherapy.
Bosch DJ; Van Dalfsen QA; Mul VE; Hospers GA; Plukker JT
Am J Surg; 2014 Aug; 208(2):215-21. PubMed ID: 24534559
[TBL] [Abstract][Full Text] [Related]
31. Respiratory function changes after chemotherapy: an additional risk for postoperative respiratory complications?
Leo F; Solli P; Spaggiari L; Veronesi G; de Braud F; Leon ME; Pastorino U
Ann Thorac Surg; 2004 Jan; 77(1):260-5; discussion 265. PubMed ID: 14726074
[TBL] [Abstract][Full Text] [Related]
32. Robot-assisted Versus Conventional Minimally Invasive Esophagectomy for Resectable Esophageal Squamous Cell Carcinoma: Early Results of a Multicenter Randomized Controlled Trial: the RAMIE Trial.
Yang Y; Li B; Yi J; Hua R; Chen H; Tan L; Li H; He Y; Guo X; Sun Y; Yu B; Li Z
Ann Surg; 2022 Apr; 275(4):646-653. PubMed ID: 34171870
[TBL] [Abstract][Full Text] [Related]
33. Comparison of complications and long-term survival after minimally invasive esophagectomy versus open esophagectomy in patients with esophageal cancer and chronic obstructive pulmonary disease.
Rong Y; Hao Y; Xue J; Li X; Li Q; Wang L; Li T
Front Oncol; 2022; 12():934950. PubMed ID: 36267968
[TBL] [Abstract][Full Text] [Related]
34. Incidence and impact of postoperative atrial fibrillation after minimally invasive esophagectomy.
Day RW; Jaroszewski D; Chang YH; Ross HJ; Paripati H; Ashman JB; Rule WG; Harold KL
Dis Esophagus; 2016 Aug; 29(6):583-8. PubMed ID: 25824527
[TBL] [Abstract][Full Text] [Related]
35. Minimally Invasive Versus Open Esophageal Resection: Three-year Follow-up of the Previously Reported Randomized Controlled Trial: the TIME Trial.
Straatman J; van der Wielen N; Cuesta MA; Daams F; Roig Garcia J; Bonavina L; Rosman C; van Berge Henegouwen MI; Gisbertz SS; van der Peet DL
Ann Surg; 2017 Aug; 266(2):232-236. PubMed ID: 28187044
[TBL] [Abstract][Full Text] [Related]
36. How does presurgical chemotherapy influence the efficiency of treatment for esophageal cancer recurrence after curative esophagectomy?
Taniyama Y; Sakurai T; Hikage M; Okamoto H; Sato C; Takaya K; Unno M; Kamei T
Thorac Cancer; 2019 Apr; 10(4):769-774. PubMed ID: 30756477
[TBL] [Abstract][Full Text] [Related]
37. Experience with minimally invasive esophagectomy.
Collins G; Johnson E; Kroshus T; Ganz R; Batts K; Seng J; Nwaneri O; Dunn D
Surg Endosc; 2006 Feb; 20(2):298-301. PubMed ID: 16362469
[TBL] [Abstract][Full Text] [Related]
38. Factors influencing the long-term survival in patients with esophageal cancer who underwent esophagectomy after chemoradiotherapy.
Takeuchi H; Saikawa Y; Oyama T; Ozawa S; Suda K; Wada N; Takahashi T; Nakamura R; Shigematsu N; Ando N; Kitajima M; Kitagawa Y
World J Surg; 2010 Feb; 34(2):277-84. PubMed ID: 20033687
[TBL] [Abstract][Full Text] [Related]
39. It's not always too late: a case for minimally invasive salvage esophagectomy.
Broderick RC; Lee AM; Blitzer RR; Zhao B; Lam J; Cheverie JN; Sandler BJ; Jacobsen GR; Onaitis MW; Kelly KJ; Bouvet M; Horgan S
Surg Endosc; 2021 Aug; 35(8):4700-4711. PubMed ID: 32940794
[TBL] [Abstract][Full Text] [Related]
40. Neoadjuvant chemoradiotherapy, chemotherapy, and radiotherapy do not significantly increase the incidence of anastomotic leakage after esophageal cancer surgery: a meta-analysis.
Jin Z; Zhang J; Chen D; Wu S; Xue P; Zhu K; Xu C; Zhu C; Zhang B
Dis Esophagus; 2022 Sep; 35(9):. PubMed ID: 34952537
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
